Gastric cancer
What Is Gastric Cancer?
Gastric cancer, also known as stomach cancer, develops when abnormal cells within the lining of the stomach begin to grow and divide uncontrollably, most often within the glandular tissue that lines the organ.
Helicobacter pylori infection is the most important risk factor for gastric cancer development, driving a well described progression of cellular changes known as the Correa gastric carcinogenesis cascade.1
This bacterial infection is implicated in up to ninety percent of gastric cancer cases, making it by far the single most significant modifiable factor in the disease’s development worldwide.1
Helicobacter pylori infection is the major etiology of gastric cancer and is implicated in up to ninety percent of cases.
National Center for Biotechnology Information
Symptoms
Early gastric cancer frequently produces no symptoms at all, which contributes significantly to delayed diagnosis in many patients.
As the disease progresses, symptoms such as persistent indigestion, abdominal discomfort, nausea, unintentional weight loss, and a feeling of fullness after eating only small amounts of food may develop.
More advanced disease can produce symptoms such as vomiting, blood in the stool, and fatigue related to anemia, reflecting the tumor’s growing impact on digestion and overall health.
Causes
Chronic Helicobacter pylori infection triggers a progressive cascade of cellular changes within the stomach lining, beginning with inflammation and potentially advancing through atrophic gastritis toward cancer over many years.1
Not everyone infected with Helicobacter pylori develops gastric cancer, suggesting that additional genetic and environmental factors influence which infected individuals ultimately progress to malignancy.2
Atrophic gastritis, a condition in which the stomach lining becomes thinned and inflamed over time, represents an important precancerous change closely linked to chronic infection.2
Risk Factors
Risk factors for gastric cancer include Helicobacter pylori infection, advancing age, high salt intake, and a diet low in fruits and vegetables.2
Atrophic gastritis and a family history of gastric cancer are also recognized as important risk factors, suggesting that both prior stomach changes and inherited susceptibility play meaningful roles.2
Because many of these risk factors are modifiable through diet, infection treatment, and lifestyle changes, gastric cancer risk reduction is an area of active clinical focus.2
Complications
Gastric cancer is diagnosed histologically following endoscopic biopsy and is then staged using imaging techniques including CT scanning, endoscopic ultrasound, PET imaging, and sometimes laparoscopy.3
Even after successful eradication of Helicobacter pylori infection, some patients remain at elevated risk for gastric cancer, particularly those with endoscopic evidence of gastric atrophy at the time of treatment.4
This ongoing risk after treatment underscores the importance of continued endoscopic surveillance in appropriately selected patients, even once the underlying infection has been resolved.4
Treatment
The main treatment for early gastric cancer is endoscopic resection, a minimally invasive procedure that removes cancerous tissue directly through an endoscope without the need for open surgery.3
For gastric cancer that is not detected at an early stage but remains operable, surgical treatment is typically required, and should include D2 lymphadenectomy, meaning removal of a defined set of surrounding lymph nodes.3
Treatment of Helicobacter pylori infection itself, through appropriate antibiotic regimens, plays an important preventive role by interrupting the carcinogenic cascade before advanced cellular changes can develop.1
Prevention
Identifying and treating Helicobacter pylori infection represents one of the most effective available strategies for reducing long term gastric cancer risk.1
For patients who have not undergone endoscopy, non invasive testing such as serum pepsinogen measurement can help predict the presence of atrophic gastritis and guide further evaluation.3
Patients found to have suspected atrophic gastritis benefit from further risk stratification through endoscopy with histologic assessment, following validated staging systems designed to guide ongoing surveillance decisions.3
Why Visual Communication Matters for Gastric Cancer
Explaining the multi step progression from Helicobacter pylori infection to atrophic gastritis to cancer requires visuals that make this gradual biological cascade clear and memorable.
Pharmaceutical companies, gastroenterology practices, and patient education organizations rely on precise illustration and animation to explain gastric cancer development and treatment approaches.
- Illustrating the Correa cascade from infection to atrophic gastritis to cancer
- Animating endoscopic resection and surgical treatment procedures
- Explaining Helicobacter pylori eradication and its role in cancer prevention
- Visualizing staging imaging techniques and their clinical role
- Supporting patient education on symptom recognition and surveillance
- Creating training materials for gastroenterology and oncology clinicians
How Biotic Artlab Supports Gastric Cancer Communication
We work with pharmaceutical companies, gastroenterology practices, and healthcare organizations to create scientifically accurate visuals that make gastric cancer easier to understand.
- Custom 3D animations of Helicobacter pylori infection and gastric carcinogenesis
- Detailed illustrations of endoscopic resection and lymphadenectomy procedures
- Mechanism of action animations for antibiotic eradication therapy
- Patient facing materials on infection treatment and cancer risk reduction
- Clinical training content for gastroenterology and oncology teams
- Conference presentations and marketing visuals for digestive oncology audiences
Frequently Asked Questions
What is the leading cause of gastric cancer?
Helicobacter pylori infection is the most important risk factor, implicated in up to ninety percent of cases worldwide.1
What is the Correa cascade?
It is the well described progression of cellular changes, from inflammation through atrophic gastritis, that can ultimately lead to gastric cancer.1
What are common symptoms of gastric cancer?
Persistent indigestion, abdominal discomfort, early fullness, and unintentional weight loss are common symptoms, particularly as disease progresses.
Does treating H. pylori eliminate gastric cancer risk?
Not entirely. Some patients, particularly those with gastric atrophy at the time of treatment, remain at elevated risk and require continued surveillance.4
How is early gastric cancer treated?
Endoscopic resection is the main treatment for early stage disease, while more advanced but operable cancer typically requires surgery.3
Can gastric cancer be prevented?
Identifying and treating Helicobacter pylori infection is one of the most effective strategies for reducing long term risk.1
Have a Project in Mind? Contact Us.
If you are developing patient education materials, clinical training content, or marketing visuals related to gastric cancer, our team can help translate the science into visuals that are both accurate and easy to understand. Contact us at info@biotic-artlab.com or get in touch through our contact form to discuss your project.
References
- National Center for Biotechnology Information. Gastric Cancer, Helicobacter Pylori Infection and Other Risk Factors.
- National Center for Biotechnology Information. Gastric Cancer.
- National Center for Biotechnology Information. Gastric Cancer Risk Stratification and Surveillance After Helicobacter Pylori Eradication.
- National Center for Biotechnology Information. Endoscopic Gastric Atrophy Is Strongly Associated With Gastric Cancer Development After Helicobacter Pylori Eradication.
Disclaimer: This page provides general educational information and is not a substitute for diagnosis, treatment, or individualized advice from a qualified healthcare professional.